Ferry Ossendorp

Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors

Ferry Ossendorp, Erica Mengedé, Marcel Camps et al. · The Journal of Experimental Medicine · 1998 · 600 citations · Full text

Cytotoxic T Lymphocytes, Class Ii, T-regulatory Cell +17

Decreased tumor surveillance in perforin-deficient mice.

Maries van den Broek, David Kägi, Ferry Ossendorp et al. · The Journal of Experimental Medicine · 1996 · 483 citations · Full text

Immunology, Nk Cells, Pathology +17

MHC II in Dendritic Cells is Targeted to Lysosomes or T Cell‐Induced Exosomes Via Distinct Multivesicular Body Pathways

Sonja I. Buschow, Esther N. M. Nolte‐‘t Hoen, Guillaume van Niel et al. · Traffic · 2009 · 409 citations · Full text

Adaptive Immune System, Immunology, Immunologic Mechanism +19

Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy

Marieke F. Fransen, Mark J.A. Schoonderwoerd, Philipp Knopf et al. · JCI Insight · 2018 · 370 citations · Full text

Lymphoid Neoplasia, Tumor Immunology, Cancer Immunosurveillance +14

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 361 citations

Dc Gene Signature, Tumor Immunology, Cancer Immunosurveillance +11